Dr. Sean Xun Wang, MD

Dr. Wang practices at Palo Alto Medical Foundation-Fremont Center in Fremont, California.

Dr. Wang's NPI, 1225295033, was assigned on May 20, 2008. Dr. Wang graduated from Joe R. & Teresa Lozano Long School of Medicine in 2008. Dr. Wang holds California license A124816.

Dr. Wang's primary practice is Palo Alto Medical Foundation-Fremont Center, at 3200 Kearney Street, Fremont, CA 94538. The practice phone is (510) 498-2812.

Dr. Wang's primary practice is Palo Alto Medical Foundation-Fremont Center in Fremont, California. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Wang to 2 more group practices and clinics and 1 medical group, each named with a free account. Dr. Wang's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Wang is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Wang is licensed in California.

Dmand AI lists acute sinusitis, chronic nasal allergies, ear infection, hearing loss and impairment, larynx and vocal cord disease, swimmer's ear, tinnitus and upper respiratory infection (URI) among the conditions Dr. Wang treats.

CMS data shows 878 Medicare services from Dr. Wang across 10 procedure codes in 2024, for 446 Medicare patients. Medicare paid $123,810 for them. Every service was in an office.

CMS counts 446 Medicare patients who saw Dr. Wang in 2024. The largest group is 75 to 84, with 181 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 48, with 55% women.

In 2024, Dr. Wang wrote 150 Medicare Part D claims for 81 patients. 97% of them were for generic drugs. CMS names the drug for 97 of them, across 4 drugs with 11 or more claims each, at $2,311 in total drug cost. In 2023, CMS named 146 claims across 6 drugs.

Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 3 papers to Dr. Wang in 2009. The most frequent topics are Carcinoma, Squamous Cell, Ethylenediamines and Head and Neck Neoplasms. Dr. Wang's most frequent co-authors are Stephanie Jo Herrera, MD, Frank R. Miller, MD and Randal A. Otto, MD.

CMS Open Payments shows 7 general payments to Dr. Wang from 5 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. ShockWave Medical, Inc paid the most, $148.

Dmand AI lists 1 award for Dr. Wang, most recently CMS Stage 1 EHR in 2013.

Dr. Wang graduated from Joe R. & Teresa Lozano Long School of Medicine in 2008.

Dr. Wang is in network with 11 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.